KT&G Life Sciences Overview
- Founded
- 2002

- Status
- Acquired/Merged
- Employees
- 30

- Latest Deal Type
- M&A
- Financing Rounds
- 2
KT&G Life Sciences General Information
Description
Developer of medicines and drugs. The company is researching drugs for treating Cancer, Obesity, Type-2 Diabetes, Liver Disease, MELAS Syndrome, Dry Eye Syndrome, Atopic Dermatitis and other metabolic diseases.
Contact Information
- B-1004-6 Digital Empire Building 16
- Deogyang-daero 1556 beon-gil Yeongtong-gu
- Suwon-si, Gyeonggi-do 443-702
- South Korea
KT&G Life Sciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore KT&G Life Sciences‘s full profile, request access.
Request a free trialKT&G Life Sciences Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialKT&G Life Sciences Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore KT&G Life Sciences‘s full profile, request access.
Request a free trial